1. Home
  2. IMMX vs UPLD Comparison

IMMX vs UPLD Comparison

Compare IMMX & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMX
  • UPLD
  • Stock Information
  • Founded
  • IMMX 2014
  • UPLD 2010
  • Country
  • IMMX United States
  • UPLD United States
  • Employees
  • IMMX N/A
  • UPLD N/A
  • Industry
  • IMMX Medicinal Chemicals and Botanical Products
  • UPLD Computer Software: Prepackaged Software
  • Sector
  • IMMX Health Care
  • UPLD Technology
  • Exchange
  • IMMX Nasdaq
  • UPLD Nasdaq
  • Market Cap
  • IMMX 51.1M
  • UPLD 52.6M
  • IPO Year
  • IMMX 2021
  • UPLD 2014
  • Fundamental
  • Price
  • IMMX $1.66
  • UPLD $2.65
  • Analyst Decision
  • IMMX Strong Buy
  • UPLD Hold
  • Analyst Count
  • IMMX 1
  • UPLD 3
  • Target Price
  • IMMX $7.00
  • UPLD $3.75
  • AVG Volume (30 Days)
  • IMMX 125.2K
  • UPLD 132.2K
  • Earning Date
  • IMMX 11-11-2024
  • UPLD 10-31-2024
  • Dividend Yield
  • IMMX N/A
  • UPLD N/A
  • EPS Growth
  • IMMX N/A
  • UPLD N/A
  • EPS
  • IMMX N/A
  • UPLD N/A
  • Revenue
  • IMMX N/A
  • UPLD $286,374,000.00
  • Revenue This Year
  • IMMX N/A
  • UPLD N/A
  • Revenue Next Year
  • IMMX $200.00
  • UPLD N/A
  • P/E Ratio
  • IMMX N/A
  • UPLD N/A
  • Revenue Growth
  • IMMX N/A
  • UPLD N/A
  • 52 Week Low
  • IMMX $1.26
  • UPLD $1.79
  • 52 Week High
  • IMMX $7.75
  • UPLD $5.28
  • Technical
  • Relative Strength Index (RSI)
  • IMMX 45.76
  • UPLD 60.09
  • Support Level
  • IMMX $1.43
  • UPLD $2.15
  • Resistance Level
  • IMMX $1.94
  • UPLD $2.85
  • Average True Range (ATR)
  • IMMX 0.13
  • UPLD 0.15
  • MACD
  • IMMX -0.01
  • UPLD 0.02
  • Stochastic Oscillator
  • IMMX 57.97
  • UPLD 71.43

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About UPLD Upland Software Inc.

Upland Software Inc is a provider of cloud-based enterprise work management software. The company provides a family of cloud-based enterprise work management software applications for the information technology, process excellence, finance, professional services and marketing functions within organizations. It services customers ranging from corporations and Government agencies to small- and medium-sized businesses engaged in the field of financial services, retail, technology, manufacturing, education, consumer goods, media, and telecommunications, Government, food and beverage, healthcare and life sciences, chemicals and travel and hospitality. The products of the company are Altify, BA Insight, InGenius, Panviva, Qvidian, RightAnswers and others.

Share on Social Networks: